Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

HealthLynked (HLYK) EBIAT (2016 - 2025)

HealthLynked (HLYK) has disclosed EBIAT for 10 consecutive years, with -$676477.0 as the latest value for Q4 2025.

  • Quarterly EBIAT rose 45.01% to -$676477.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.3 million through Dec 2025, up 46.5% year-over-year, with the annual reading at -$3.3 million for FY2025, 46.5% up from the prior year.
  • EBIAT for Q4 2025 was -$676477.0 at HealthLynked, up from -$851800.0 in the prior quarter.
  • The five-year high for EBIAT was $1.5 million in Q1 2023, with the low at -$7.8 million in Q1 2021.
  • Average EBIAT over 5 years is -$1.4 million, with a median of -$1.1 million recorded in 2022.
  • The sharpest move saw EBIAT crashed 1248.37% in 2021, then skyrocketed 224.3% in 2023.
  • Over 5 years, EBIAT stood at -$1.7 million in 2021, then tumbled by 105.54% to -$3.5 million in 2022, then skyrocketed by 63.53% to -$1.3 million in 2023, then rose by 4.32% to -$1.2 million in 2024, then skyrocketed by 45.01% to -$676477.0 in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at -$676477.0, -$851800.0, and -$701038.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.